{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:01:56Z","timestamp":1791406916918,"version":"4.3.3"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Institute of Health","award":["R01EB013198"],"award-info":[{"award-number":["R01EB013198"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jconrel.2019.02.025","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T21:40:12Z","timestamp":1551217212000},"page":"185-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"special_numbering":"C","title":["Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation"],"prefix":"10.1016","volume":"300","author":[{"given":"Eiji","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Gohel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.C.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonnie D.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2019.02.025_bb0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.immunol.26.021607.090326","article-title":"Monocyte-mediated defense against microbial pathogens","volume":"26","author":"Serbina","year":"2008","journal-title":"Annu.Rev.Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0010","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat.Rev.Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nri2779","article-title":"Phagocyte partnership during the onset and resolution of inflammation","volume":"10","author":"Soehnlein","year":"2010","journal-title":"Nat.Rev.Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0020","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri3671","article-title":"Monocytes and macrophages: developmental pathways and tissue homeostasis","volume":"14","author":"Ginhoux","year":"2014","journal-title":"Nat.Rev.Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","article-title":"Neutrophil recruitment and function in health and inflammation","volume":"13","author":"Kolaczkowska","year":"2013","journal-title":"Nat.Rev.Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0030","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.it.2011.05.001","article-title":"Monocyte trafficking in acute and chronic inflammation","volume":"32","author":"Ingersoll","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0035","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1128\/IAI.67.12.6603-6610.1999","article-title":"Immunopathologic alterations in murine models of sepsis of increasing severity","volume":"67","author":"Ebong","year":"1999","journal-title":"Infect.Immun."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0040","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1378\/chest.13-2104","article-title":"Early management of severe sepsis: concepts and controversies","volume":"145","author":"Marik","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0045","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrneurol.2015.144","article-title":"Immune interventions in stroke","volume":"11","author":"Fu","year":"2015","journal-title":"Nat.Rev.Neurol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0050","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s11095-014-1545-6","article-title":"Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance","volume":"32","author":"Mc Carthy","year":"2015","journal-title":"Pharm.Res."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.mce.2007.05.009","article-title":"Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice","volume":"275","author":"Kleiman","year":"2007","journal-title":"Mol.Cell.Endocrinol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12026-015-8719-0","article-title":"Advancing drug delivery systems for the treatment of multiple sclerosis","volume":"63","author":"Tabansky","year":"2015","journal-title":"Immunol.Res."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0065","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/ni1275","article-title":"Immune cell migration in inflammation: present and future therapeutic targets","volume":"6","author":"Luster","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0070","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nature08604","article-title":"Materials engineering for immunomodulation","volume":"462","author":"Hubbell","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0075","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nbt.2434","article-title":"Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis","volume":"30","author":"Getts","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0080","doi-asserted-by":"crossref","first-page":"11270","DOI":"10.1073\/pnas.1120611109","article-title":"Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis","volume":"109","author":"Yeste","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molimm.2013.08.006","article-title":"A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis","volume":"57","author":"Yuan","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jnc.13892","article-title":"Attenuation of experimental autoimmune neuritis with locally administered lovastatin-encapsulating poly(lactic-co-glycolic) acid nanoparticles","volume":"140","author":"Langert","year":"2017","journal-title":"J.Neurochem."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/srep29601","article-title":"Nanoparticle-mediated delivery of irbesartan induces cardioprotection from myocardial ischemia-reperfusion injury by antagonizing monocyte-mediated inflammation","volume":"6","author":"Nakano","year":"2016","journal-title":"Sci.Rep."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0100","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1021\/mp500473d","article-title":"Therapeutic aerosol bioengineering of siRNA for the treatment of inflammatory lung disease by TNFalpha gene silencing in macrophages","volume":"11","author":"Kelly","year":"2014","journal-title":"Mol.Pharm."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev-pharmtox-011613-140002","article-title":"Nanocarriers for vascular delivery of anti-inflammatory agents","volume":"54","author":"Howard","year":"2014","journal-title":"Annu.Rev.Pharmacol.Toxicol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijpharm.2008.04.042","article-title":"Principles of encapsulating hydrophobic drugs in PLA\/PLGA microparticles","volume":"364","author":"Wischke","year":"2008","journal-title":"Int.J.Pharm."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0115","doi-asserted-by":"crossref","first-page":"219ra7","DOI":"10.1126\/scitranslmed.3007563","article-title":"Therapeutic inflammatory monocyte modulation using immune-modifying microparticles","volume":"6","author":"Getts","year":"2014","journal-title":"Sci.Transl.Med."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nbd.2017.08.006","article-title":"Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice","volume":"108","author":"Jeong","year":"2017","journal-title":"Neurobiol.Dis."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0125","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1016\/j.biomaterials.2012.06.003","article-title":"Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response","volume":"33","author":"Webber","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0130","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1016\/j.biomaterials.2013.06.051","article-title":"Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction","volume":"34","author":"Somasuntharam","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0135","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.7b03190","article-title":"Neutrophil-particle interactions in blood circulation drive particle clearance and alter neutrophil responses in acute inflammation","author":"Fromen","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0140","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/toxsci\/kfm050","article-title":"A murine scavenger receptor MARCO recognizes polystyrene nanoparticles","volume":"97","author":"Kanno","year":"2007","journal-title":"Toxicol.Sci."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0145","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11095-008-9760-7","article-title":"Polymer chemistry influences monocytic uptake of polyanhydride nanospheres","volume":"26","author":"Ulery","year":"2009","journal-title":"Pharm.Res."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J.Control.Release."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.actbio.2016.11.012","article-title":"Poly(lactic acid)-based particulate systems are promising tools for immune modulation","volume":"48","author":"Peres","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1084\/jem.20141015","article-title":"Neutrophil-related factors as biomarkers in EAE and MS","volume":"212","author":"Rumble","year":"2015","journal-title":"J.Exp.Med."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.nano.2016.09.007","article-title":"An antigen-encapsulating nanoparticle platform for TH1\/17 immune tolerance therapy","volume":"13","author":"McCarthy","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0170","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1016\/j.biomaterials.2009.05.074","article-title":"Simultaneous release of multiple molecules from poly(lactide-co-glycolide) nanoparticles assembled onto medical devices","volume":"30","author":"Lo","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1501s88","article-title":"Experimental autoimmune encephalomyelitis in the mouse","author":"Miller","year":"2010","journal-title":"Curr.Protoc.Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0180","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaut.2006.12.002","article-title":"Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities","volume":"27","author":"Smith","year":"2006","journal-title":"J.Autoimmun."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0185","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/nn405033r","article-title":"A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease","volume":"8","author":"Hunter","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0190","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1182\/blood-2008-07-168575","article-title":"Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease","volume":"113","author":"King","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0195","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.4049\/jimmunol.179.8.5228","article-title":"CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis","volume":"179","author":"Zhu","year":"2007","journal-title":"J.Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0200","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0142-9612(00)00034-X","article-title":"Neutrophil activation by plasma opsonized polymeric microspheres: inhibitory effect of pluronic F127","volume":"21","author":"Jackson","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0205","first-page":"5965","article-title":"Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages","volume":"10","author":"Guedj","year":"2015","journal-title":"Int.J.Nanomedicine."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0210","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1503\/cmaj.130727","article-title":"Drug therapy for multiple sclerosis","volume":"186","author":"Tavazzi","year":"2014","journal-title":"CMAJ"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0215","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4049\/jimmunol.1501202","article-title":"Monocyte-derived dendritic cells promote Th polarization, whereas conventional dendritic cells promote Th proliferation","volume":"196","author":"Chow","year":"2016","journal-title":"J.Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0220","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/978-1-60761-720-4_18","article-title":"Experimental autoimmune encephalomyelitis","volume":"900","author":"Rao","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0225","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jconrel.2013.09.013","article-title":"Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles","volume":"172","author":"Ernsting","year":"2013","journal-title":"J.Control.Release."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0230","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3109\/03602532.2013.864664","article-title":"The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats","volume":"46","author":"Simon","year":"2014","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Shive","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2006.07.030","article-title":"Degradation behaviour of microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers","volume":"326","author":"Blanco","year":"2006","journal-title":"Int.J.Pharm."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0245","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1167\/iovs.16-20668","article-title":"Murine corneal inflammation and nerve damage after infection with HSV-1 are promoted by HVEM and ameliorated by immune-modifying nanoparticle therapy","volume":"58","author":"Edwards","year":"2017","journal-title":"Invest.Ophthalmol.Vis.Sci."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0250","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0168-3659(01)00413-8","article-title":"Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells","volume":"76","author":"Walter","year":"2001","journal-title":"J.Control.Release."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0255","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/jbm.820221002","article-title":"Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid\/glycolic acid homo- and copolymers","volume":"22","author":"Tabata","year":"1988","journal-title":"J.Biomed.Mater.Res."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0260","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/mp100255c","article-title":"Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine","volume":"8","author":"Thomas","year":"2011","journal-title":"Mol.Pharm."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.smim.2017.09.011","article-title":"Effects of engineered nanoparticles on the innate immune system","volume":"34","author":"Liu","year":"2017","journal-title":"Semin.Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0270","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nnano.2014.62","article-title":"Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery","volume":"9","author":"Smith","year":"2014","journal-title":"Nat.Nanotechnol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0275","doi-asserted-by":"crossref","first-page":"10758","DOI":"10.1021\/acsnano.5b05061","article-title":"Modulatory role of surface coating of superparamagnetic iron oxide nanoworms in complement opsonization and leukocyte uptake","volume":"9","author":"Inturi","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0280","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nnano.2014.17","article-title":"Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils","volume":"9","author":"Wang","year":"2014","journal-title":"Nat.Nanotechnol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0285","doi-asserted-by":"crossref","first-page":"11800","DOI":"10.1021\/acsnano.5b05583","article-title":"Neutrophil-mediated delivery of therapeutic nanoparticles across blood vessel barrier for treatment of inflammation and infection","volume":"9","author":"Chu","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0290","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1166\/jbn.2014.1693","article-title":"Interaction of N-(2-hydroxypropyl)methacrylamide based homo, random and block copolymers with primary immune cells","volume":"10","author":"Weilbacher","year":"2014","journal-title":"J.Biomed.Nanotechnol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026078","article-title":"High and low molecular weight hyaluronic acid differentially regulate human fibrocyte differentiation","volume":"6","author":"Maharjan","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0300","article-title":"Endocytosis and exocytosis of nanoparticles in mammalian cells","author":"Oh","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0305","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1002\/anie.200700465","article-title":"Detailed identification of plasma proteins adsorbed on copolymer nanoparticles","volume":"46","author":"Cedervall","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0310","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00600-w","article-title":"Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0315","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.intimp.2011.05.014","article-title":"The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response","volume":"11","author":"Nicolete","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049635","article-title":"Acidic nanoparticles are trafficked to lysosomes and restore an acidic lysosomal pH and degradative function to compromised ARPE-19 cells","volume":"7","author":"Baltazar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0325","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bbrc.2015.01.005","article-title":"Lactic acid delays the inflammatory response of human monocytes","volume":"457","author":"Peter","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0330","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.nano.2013.04.003","article-title":"PLGA nanoparticles loaded with KMP-11 stimulate innate immunity and induce the killing of Leishmania","volume":"9","author":"Santos","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0335","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn.2887","article-title":"Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool","volume":"14","author":"Ajami","year":"2011","journal-title":"Nat.Neurosci."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0340","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1093\/brain\/awp144","article-title":"CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system","volume":"132","author":"Mildner","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.05.007","article-title":"The spleen as a neuroimmune interface after spinal cord injury","volume":"321","author":"Noble","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0350","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1039\/c3nr04013e","article-title":"Design of hybrid multimodal poly(lactic-co-glycolic acid) polymer nanoparticles for neutrophil labeling, imaging and tracking","volume":"5","author":"Qiu","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2019.02.025_bb0355","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.1202613","article-title":"Neutrophils amplify autoimmune central nervous system infiltrates by maturing local APCs","volume":"191","author":"Steinbach","year":"2013","journal-title":"J.Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0360","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clim.2016.06.017","article-title":"The contribution of neutrophils to CNS autoimmunity","volume":"189","author":"Pierson","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0365","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.4049\/jimmunol.1400401","article-title":"Neutrophils mediate blood\u2013spinal cord barrier disruption in demyelinating neuroinflammatory diseases","volume":"193","author":"Aub\u00e9","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2019.02.025_bb0370","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919301087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919301087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:41:37Z","timestamp":1759160497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919301087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":74,"alternative-id":["S0168365919301087"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.02.025","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}